Clinical Trials Directory

Trials / Completed

CompletedNCT01759316

Heliox in Preterm Infants With Respiratory Distress Syndrome

Nasal Intermittent Positive Pressure Ventilation and Mechanical Ventilation With Heliox in Preterm Infants With Respiratory Distress Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Third Military Medical University · Academic / Other
Sex
All
Age
28 Weeks – 37 Weeks
Healthy volunteers
Not accepted

Summary

Heliox can lower respiratory resistance, improve the oxygenation, reduce respiratory distress and lung injury caused by mechanical ventilation.

Detailed description

Heliox can improve the oxygenation, reduce respiratory distress and lung injury caused by mechanical ventilation. Heliox has not been widely used. More studies on the effects and safety of Heliox in addition to NIPPV and mechanical ventilation should be tried.

Conditions

Interventions

TypeNameDescription
OTHERhelioxheliox or oxygen is used in the two groups respectively

Timeline

Start date
2012-12-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2013-01-03
Last updated
2013-10-28

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT01759316. Inclusion in this directory is not an endorsement.